Maynard Ryan D 4
4 · Cara Therapeutics, Inc. · Filed Sep 14, 2022
Insider Transaction Report
Form 4
Maynard Ryan D
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-09-12+225,000→ 225,000 totalExercise: $10.75Exp: 2032-09-12→ Common Stock (225,000 underlying)
Footnotes (1)
- [F1]25% of the shares will vest and become exercisable on September 12, 2023 and the remainder will vest over the following 36 equal monthly installments, in each case, subject to the Reporting Person's continued service to the Issuer as of each such date.